PL3384915T3 - Karymycyna do leczenia zakażeń prątkiem gruźlicy - Google Patents
Karymycyna do leczenia zakażeń prątkiem gruźlicyInfo
- Publication number
- PL3384915T3 PL3384915T3 PL16880885T PL16880885T PL3384915T3 PL 3384915 T3 PL3384915 T3 PL 3384915T3 PL 16880885 T PL16880885 T PL 16880885T PL 16880885 T PL16880885 T PL 16880885T PL 3384915 T3 PL3384915 T3 PL 3384915T3
- Authority
- PL
- Poland
- Prior art keywords
- carrimycin
- treatment
- mycobacterium tuberculosis
- tuberculosis infections
- infections
- Prior art date
Links
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511030787.7A CN105497053B (zh) | 2015-12-31 | 2015-12-31 | 可利霉素在抗结核分枝杆菌感染中的应用 |
| PCT/CN2016/108502 WO2017114095A1 (zh) | 2015-12-31 | 2016-12-05 | 可利霉素在抗结核分枝杆菌感染中的应用 |
| EP16880885.5A EP3384915B1 (en) | 2015-12-31 | 2016-12-05 | Carrimycin for the treatment of mycobacterium tuberculosis infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3384915T3 true PL3384915T3 (pl) | 2020-09-07 |
Family
ID=55705614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16880885T PL3384915T3 (pl) | 2015-12-31 | 2016-12-05 | Karymycyna do leczenia zakażeń prątkiem gruźlicy |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11000708B2 (pl) |
| EP (1) | EP3384915B1 (pl) |
| JP (1) | JP6770584B2 (pl) |
| KR (1) | KR20180098624A (pl) |
| CN (1) | CN105497053B (pl) |
| AU (1) | AU2016382584B2 (pl) |
| BR (1) | BR112018013327A2 (pl) |
| CA (1) | CA3010020A1 (pl) |
| CL (1) | CL2018001804A1 (pl) |
| CO (1) | CO2018007133A2 (pl) |
| DK (1) | DK3384915T3 (pl) |
| ES (1) | ES2785644T3 (pl) |
| MY (1) | MY191800A (pl) |
| PE (1) | PE20190210A1 (pl) |
| PH (1) | PH12018501394A1 (pl) |
| PL (1) | PL3384915T3 (pl) |
| RU (1) | RU2733382C2 (pl) |
| UA (1) | UA121159C2 (pl) |
| WO (1) | WO2017114095A1 (pl) |
| ZA (1) | ZA201804398B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497053B (zh) * | 2015-12-31 | 2018-02-13 | 沈阳福洋医药科技有限公司 | 可利霉素在抗结核分枝杆菌感染中的应用 |
| MX2019011973A (es) * | 2017-04-06 | 2019-11-08 | Shenyang Fuyang Pharmaceutical Tech Co Ltd | Uso de la carrimicina y las sales farmaceuticamente aceptables de esta para la preparacion de medicamentos para el tratamiento y/o la prevencion de tumores. |
| CN110384710B (zh) * | 2018-04-17 | 2023-01-10 | 沈阳福洋医药科技有限公司 | 一种用于预防和/或治疗疼痛的药物、组合产品及其应用 |
| CN110384802B (zh) * | 2018-04-17 | 2021-09-17 | 沈阳福洋医药科技有限公司 | 一种用于预防和/或治疗发热的药物、组合产品及其应用 |
| WO2021219112A1 (zh) * | 2020-04-30 | 2021-11-04 | 沈阳福洋医药科技有限公司 | 异戊酰螺旋霉素类化合物或其组合物在制备治疗脓毒症疾病药物中的应用 |
| CN113577086B (zh) * | 2020-04-30 | 2023-05-02 | 沈阳福洋医药科技有限公司 | 异戊酰螺旋霉素类化合物或其组合物在制备治疗免疫失调的药物中的应用 |
| WO2022119899A1 (en) * | 2020-12-02 | 2022-06-09 | Shionogi & Co., Ltd. | A medicament for treating mycobacterial infection characterized by combining a cytochrome bc1 inhibitor with clarithromycin or azithromycin |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2126108B1 (pl) * | 1971-02-25 | 1974-08-02 | Rhone Poulenc Sa | |
| US7098219B2 (en) * | 2000-08-01 | 2006-08-29 | Wockhart Limited | Inhibitors of cellular efflux pumps of microbes |
| CN1237976C (zh) * | 2003-12-23 | 2006-01-25 | 沈阳同联集团有限公司 | 必特螺旋霉素及其在抗感染性疾病中的应用 |
| WO2006055663A2 (en) * | 2004-11-17 | 2006-05-26 | Smithkline Beecham Corporation | The use of novel antibacterial compounds |
| DE102005058345A1 (de) * | 2005-12-06 | 2007-06-14 | Kern, Andreas, Dr. med. | Verwendung eines oral einzunehmenden Antibiotikums |
| WO2008122038A1 (en) * | 2007-04-02 | 2008-10-09 | President And Fellows Of Harvard College | Regulating autophagy |
| US9089586B2 (en) * | 2010-05-25 | 2015-07-28 | Shenyang Tonglian Group Co., Ltd. | Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof |
| PL3210991T3 (pl) * | 2010-05-25 | 2020-03-31 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie |
| JP6116206B2 (ja) * | 2012-11-26 | 2017-04-19 | クリニプロ株式会社 | 吸入用パウダーの製造方法 |
| CN103142520B (zh) * | 2013-03-15 | 2015-04-01 | 沈阳同联集团有限公司 | 一种可利霉素片及其制备方法 |
| CN105497053B (zh) * | 2015-12-31 | 2018-02-13 | 沈阳福洋医药科技有限公司 | 可利霉素在抗结核分枝杆菌感染中的应用 |
-
2015
- 2015-12-31 CN CN201511030787.7A patent/CN105497053B/zh active Active
-
2016
- 2016-12-05 MY MYPI2018001121A patent/MY191800A/en unknown
- 2016-12-05 RU RU2018125622A patent/RU2733382C2/ru active
- 2016-12-05 US US16/067,327 patent/US11000708B2/en active Active
- 2016-12-05 ES ES16880885T patent/ES2785644T3/es active Active
- 2016-12-05 UA UAA201808048A patent/UA121159C2/uk unknown
- 2016-12-05 KR KR1020187021578A patent/KR20180098624A/ko active Search and Examination
- 2016-12-05 CA CA3010020A patent/CA3010020A1/en active Pending
- 2016-12-05 JP JP2018553283A patent/JP6770584B2/ja active Active
- 2016-12-05 PL PL16880885T patent/PL3384915T3/pl unknown
- 2016-12-05 WO PCT/CN2016/108502 patent/WO2017114095A1/zh active Application Filing
- 2016-12-05 AU AU2016382584A patent/AU2016382584B2/en active Active
- 2016-12-05 BR BR112018013327-2A patent/BR112018013327A2/pt active Search and Examination
- 2016-12-05 DK DK16880885.5T patent/DK3384915T3/da active
- 2016-12-05 EP EP16880885.5A patent/EP3384915B1/en active Active
- 2016-12-05 PE PE2018001212A patent/PE20190210A1/es unknown
-
2018
- 2018-06-28 PH PH12018501394A patent/PH12018501394A1/en unknown
- 2018-06-29 ZA ZA2018/04398A patent/ZA201804398B/en unknown
- 2018-06-29 CL CL2018001804A patent/CL2018001804A1/es unknown
- 2018-07-09 CO CONC2018/0007133A patent/CO2018007133A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019501220A (ja) | 2019-01-17 |
| EP3384915B1 (en) | 2020-02-19 |
| RU2018125622A3 (pl) | 2020-03-26 |
| EP3384915A4 (en) | 2018-12-19 |
| DK3384915T3 (en) | 2020-05-04 |
| MY191800A (en) | 2022-07-15 |
| CA3010020A1 (en) | 2017-07-06 |
| EP3384915A1 (en) | 2018-10-10 |
| PH12018501394A1 (en) | 2019-02-27 |
| ES2785644T3 (es) | 2020-10-07 |
| UA121159C2 (uk) | 2020-04-10 |
| US20190001160A1 (en) | 2019-01-03 |
| PE20190210A1 (es) | 2019-02-07 |
| CO2018007133A2 (es) | 2018-07-19 |
| WO2017114095A1 (zh) | 2017-07-06 |
| JP6770584B2 (ja) | 2020-10-14 |
| AU2016382584A1 (en) | 2018-07-26 |
| KR20180098624A (ko) | 2018-09-04 |
| AU2016382584B2 (en) | 2022-01-06 |
| ZA201804398B (en) | 2019-09-25 |
| RU2018125622A (ru) | 2020-01-31 |
| CN105497053B (zh) | 2018-02-13 |
| US11000708B2 (en) | 2021-05-11 |
| RU2733382C2 (ru) | 2020-10-01 |
| BR112018013327A2 (pt) | 2018-12-04 |
| CL2018001804A1 (es) | 2018-09-28 |
| CN105497053A (zh) | 2016-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263972A (en) | Dihydropyranopyrimidines for the treatment of viral infections | |
| IL255270A0 (en) | exoskeleton | |
| IL247155A0 (en) | Rapamycin for the treatment of lymphangioleiomyomatosis | |
| SG11201609652RA (en) | Treatment of polybacterials infections | |
| PL3384915T3 (pl) | Karymycyna do leczenia zakażeń prątkiem gruźlicy | |
| SI3538379T1 (sl) | Sistem za delanje zapiskov, ki omogoča brisanje z vlago | |
| SG11201702688UA (en) | Methods of treating rsv infections | |
| HK1258276A1 (zh) | 用於治療hiv的化合物和組合 | |
| GB201608885D0 (en) | Treatment | |
| PT3307267T (pt) | Tratamento de esclerose múltipla | |
| GB201522243D0 (en) | Treatment | |
| GB201502137D0 (en) | Treatment | |
| HRP20191486T1 (hr) | Heterobiciklički spojevi i njihova uporaba za liječenje tuberkuloze | |
| HK1257272A1 (zh) | 治療hiv的工具 | |
| ZA201906047B (en) | Compounds for treating tuberculosis | |
| HK1247558A1 (zh) | 塞內可瑞偉洛克(cenicriviroc)用於治療纖維化 | |
| GB201519450D0 (en) | Novel treatment | |
| GB201508841D0 (en) | Treatment | |
| GB201620323D0 (en) | Treatment Device | |
| EP3448869A4 (en) | AZASTEROIDS FOR TUBERCULOSIS TREATMENT | |
| RS58951B1 (sr) | Lečenje multiple skleroze | |
| IL249616A0 (en) | Methods for treating inflammation | |
| ZA201901948B (en) | Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections | |
| GB201503008D0 (en) | Treatment | |
| GB201617107D0 (en) | Treatment |